Portal de Periódicos da CAPES

Imaging as a Biomarker for Therapy Response: Cancer as a Prototype for the Creation of Research Resources

2008; Wiley; Volume: 84; Issue: 4 Linguagem: Inglês

10.1038/clpt.2008.171

1532-6535

Geoffrey McLennan, Laurence P. Clarke, RJ Hohl,

Lung Cancer Treatments and Mutations

Clinical Pharmacology & TherapeuticsVolume 84, Issue 4 p. 433-436 Editorial Imaging as a Biomarker for Therapy Response: Cancer as a Prototype for the Creation of Research Resources G McLennan, Corresponding Author G McLennan [email protected] Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USASearch for more papers by this authorL Clarke, L Clarke Cancer Imaging Program, National Cancer Institute, Bethesda, Maryland, USASearch for more papers by this authorRJ Hohl, RJ Hohl Division of Hematology, Oncology, and Blood & Marrow Transplantation and Division of Clinical Pharmacology, Departments of Internal Medicine and Pharmacology, University of Iowa, Iowa City, Iowa, USASearch for more papers by this author G McLennan, Corresponding Author G McLennan [email protected] Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USASearch for more papers by this authorL Clarke, L Clarke Cancer Imaging Program, National Cancer Institute, Bethesda, Maryland, USASearch for more papers by this authorRJ Hohl, RJ Hohl Division of Hematology, Oncology, and Blood & Marrow Transplantation and Division of Clinical Pharmacology, Departments of Internal Medicine and Pharmacology, University of Iowa, Iowa City, Iowa, USASearch for more papers by this author First published: 18 September 2008 https://doi.org/10.1038/clpt.2008.171Citations: 3Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 National Cancer Institute. Report of the Clinical Trials Working Group of the National Cancer Advisory Board: Restructuring the National Cancer Clinical Trials Enterprise (June 2005). Google Scholar 2 US Food and Drug Administration. FDA's Critical Path Initiative (2008). Google Scholar 3Shankar, L.K. et al. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute trials. J. Nucl. Med. 47, 1059–1066 (2006) . CASPubMedWeb of Science®Google Scholar 4 National Cancer Institute. Cancer Imaging Program. Magnetic Resonance . Google Scholar 5 National Cancer Institute. Cancer Imaging Program. Lung Imaging Database Consortium (LIDC) . Google Scholar 6 Foundation for the National Institutes of Health. Imaging Database Resources Initiative (IDRI) (9 September 2005). Google Scholar 7 National Cancer Institute. National Cancer Imaging Archive . Google Scholar 8 Association of American Cancer Institutes. RIDER Database Resource and Plans for a Public Private Partnership Google Scholar 9Armato, S.G. III. et al. The Reference Image Database to Evaluate Response to Therapy in lung cancer (RIDER) project: a resource for the development of change-analysis software. http://dx.doi.org/10.1038/clpt.2008.161Clin. Pharmacol. Ther. 84, 448–456 (2008). 10.1038/clpt.2008.161 CASPubMedWeb of Science®Google Scholar 10 National Institute of Standards and Technology. U.S. Measurement System. USMS Workshops. Imaging as a Biomarker: Standards for Change Measurements in Therapy, 14–15 September 2006, NIST Gaithersburg, Maryland . Google Scholar 11 Association of American Cancer Institutes. The IRAT Network. Imaging Response Assessment Teams . Google Scholar 12 National Cancer Institute. caBIG Cancer Biomedical Informatics Grid. In Vivo Imaging (IMAG) Workspace . Google Scholar 13 National Cancer Institute. Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) . Google Scholar 14Suter, M.J., Reinhardt, J.M. & McLennan, G. Integrated CT/ bronchoscopy in the central airways: preliminary results. Acad. Radiol. 15, 786–798 (2008). 10.1016/j.acra.2008.03.001 PubMedWeb of Science®Google Scholar Citing Literature Volume84, Issue4ImagingOctober 2008Pages 433-436 ReferencesRelatedInformation